FRA
WST icon

Frank Rimerman Advisors’s West Pharmaceutical WST Stock Holding History

Frank Rimerman Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,835
Closed -$851K – 567
2024
Q3 		$851K Sell
2,835
-24
-0.8% -$7.35K 0.06% 243
2024
Q2 		$942K Buy
+2,859
New +$1.01M 0.07% 231
2022
Q2 		– Sell
-2,499
Closed -$1.03M – 130
2022
Q1 		$1.03M Hold
2,499
– – 0.33% 40
2021
Q4 		$1.17M Buy
2,499
+452
+22% +$195K 0.39% 39
2021
Q3 		$869K Buy
+2,047
New +$863K 0.34% 41

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Frank Rimerman Advisors's WST Position: Q4 2024 in Review

Frank Rimerman Advisors sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 2,835 shares — an estimated $851K sold.

Frank Rimerman Advisors first reported a position in WST in Q3 2021 and held it in 5 quarters. The position peaked at $1.17M in Q4 2021. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Frank Rimerman Advisors reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Frank Rimerman Advisors sold 2,835 West Pharmaceutical shares in Q4 2024, an estimated $851K.
  • Frank Rimerman Advisors first reported a position in West Pharmaceutical in Q3 2021 and held it in 5 quarters.
  • Frank Rimerman Advisors's West Pharmaceutical position peaked at $1.17M in Q4 2021.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Frank Rimerman Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.